Viral Hepatitis A, B & C: Surveillance, Prevention & Control
Last Updated on January 25, 2020 by HepFree NYC
Related Articles
-
Support the NYC Hep B Universal Birth Dose Initiative
The New York City Department of Health and Mental Hygiene is currently completing the first segment of a project that aims to gather support for the hepatitis B birth dose in New York City.
-
NY Hepatitis Data Reports
Find New York City and State viral hepatitis surveillance data to help with reports, grant applications, advocacy and more!
-
NYS Medicaid Adds Epclusa and Viekira XR to Preferred Hep C Med List
The NYS Medicaid Drug Utilization Review Board met on September 15, 2016 and added Epclusa (GT 2 and 3) and Viekira XR to the preferred prescription medication list.
-
Hep C Medication Prior Authorization Requirements Reduced in NYS Fee for Service Medicaid
NYS Medicaid FFS removed prior authorizations for first time direct acting antivirals (DAAs) treatment of Hep C infection and for re-treatment within one year for any reason.
-
NYS Hep C ‘Baby Boomer’ Testing Law
NYS Hep C 'Baby Boomer' Testing Law Background on the Law Effective January 1, 2014, the NYS Hepatitis C Testing Law. 2171 requires healthcare providers to offer hep C test to baby boomers. The law requires full diagnostic testing for those who screen anti-body positive and ei...
-
O’Neill Institute Launches Hep C Policy Project
The O’Neill Institute for National and Global Health Law, a part of the Georgetown Law, announces the launch of the Hepatitis Policy Project (HPP) to focus on issues and barriers of access to effective treatments for hepatitis C.
-
NYS DOH Removes Hep C Med Restrictions in FFS Medicaid
The NYS Drug Utilization Review Board voted to eliminate most restrictions on prescribing hepatitis C medications for all Medicaid fee-for-service patients.
-
Job | Hep C Program Manager @ Housing Works
The Hepatitis C Program Manager is responsible for the implementation, management, and administration of an AIDS Institute–funded Hepatitis C treatment program.
